Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.

1,218 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Transparency, Reproducibility, and the Credibility of Economics Research (2018, neutral): “2008), and patient-reported outcomes (Calvert et al. 2013).”
Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures (2014, neutral): “…in Epidemiology) [4], TREND (Transparent Reporting of Evaluations with Nonrandomized Designs) [5], STARD (STAndards for the Reporting of Diagnostic accuracy studies) [6], STREGA (Strengthening the reporting of gen-etic association studies) [7], as well as in the recently published CONSORT PRO [8].”
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension (2018, methodology): “it is recommended that careful consideration be given to the selectionof outcomesandmeasures,(36,37) analysis of PROdata,(4,5,38) and transparent reporting in accordance with CONSORT-PRO.(17) Pa-”
The CARE Guidelines: Consensus-based Clinical Case Report Guideline Development (2013, neutral): “In a similar vein, a recent extension of the CONSORT statement was published for patient-reported outcomes in randomized trials; CONSORT-PRO (Calvert et al., 2013).”